InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-21 · accession 0001415889-24-025507 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-10-22 2024-10-21 UTHR EDGEMOND JAMES CFO AND Treas S - Sale+OE $366.99 -7,782 6,695 -54% -$2.86M
DM 2024-10-22 2024-10-21 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $118.99 +8,334 7,243 New +$991.6K
DM 2024-10-22 2024-10-21 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $0.00 -8,334 120.0K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-21 S D 567 $366.99 6,978 D — —
2 Common Common Stock 2024-10-21 M A 850 $117.76 7,545 D — —
3 Common Common Stock 2024-10-21 M A 3,267 $120.26 9,693 D — —
4 Common Common Stock 2024-10-21 S D 3,267 $366.99 6,426 D — —
5 Common Common Stock 2024-10-21 M A 3,400 $117.76 9,826 D — —
6 Common Common Stock 2024-10-21 S D 3,400 $366.99 6,426 D — —
7 Common Common Stock 2024-10-21 M A 817 $120.26 7,243 D — —
8 Common Common Stock 2024-10-21 S D 548 $366.99 6,695 D — —
9 Derivative Stock Options 2024-10-21 M D 3,267 $0.00 8,985 D $120.26 · 2017-03-15 to 2026-03-15 3,267 Common Stock
10 Derivative Stock Options 2024-10-21 M D 817 $0.00 8,168 D $120.26 · 2017-03-15 to 2026-03-15 817 Common Stock
11 Derivative Stock Options 2024-10-21 M D 3,400 $0.00 120,850 D $117.76 · 2021-03-15 to 2027-03-15 3,400 Common Stock
12 Derivative Stock Options 2024-10-21 M D 850 $0.00 120,000 D $117.76 · 2021-03-15 to 2027-03-15 850 Common Stock